Report Detail

Other Global Clinical Next-Generation Sequencing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM2839338
  • |
  • 30 January, 2019
  • |
  • Global
  • |
  • 123 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.

Scope of the Report:
The global Clinical Next-Generation Sequencing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Clinical Next-Generation Sequencing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Clinical Next-Generation Sequencing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Clinical Next-Generation Sequencing market by product type and applications/end industries.

Market Segment by Companies, this report covers
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Targeted Sequencing
Exome Sequencing
Others

Market Segment by Applications, can be divided into
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others


Table of Contents

    1 Clinical Next-Generation Sequencing Market Overview

    • 1.1 Product Overview and Scope of Clinical Next-Generation Sequencing
    • 1.2 Classification of Clinical Next-Generation Sequencing by Types
      • 1.2.1 Global Clinical Next-Generation Sequencing Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Types in 2018
      • 1.2.3 Targeted Sequencing
      • 1.2.4 Exome Sequencing
      • 1.2.5 Others
    • 1.3 Global Clinical Next-Generation Sequencing Market by Application
      • 1.3.1 Global Clinical Next-Generation Sequencing Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospitals and Clinics
      • 1.3.3 Biopharma Companies
      • 1.3.4 Academic and Research Organizations
      • 1.3.5 Others
    • 1.4 Global Clinical Next-Generation Sequencing Market by Regions
      • 1.4.1 Global Clinical Next-Generation Sequencing Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Clinical Next-Generation Sequencing (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Thermo Fisher Scientific
      • 2.1.1 Business Overview
      • 2.1.2 Clinical Next-Generation Sequencing Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 PerkinElmer
      • 2.2.1 Business Overview
      • 2.2.2 Clinical Next-Generation Sequencing Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 PerkinElmer Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Illumina
      • 2.3.1 Business Overview
      • 2.3.2 Clinical Next-Generation Sequencing Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Illumina Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Beckman Coulter
      • 2.4.1 Business Overview
      • 2.4.2 Clinical Next-Generation Sequencing Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Beckman Coulter Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 GATC Biotech
      • 2.5.1 Business Overview
      • 2.5.2 Clinical Next-Generation Sequencing Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 GATC Biotech Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Qiagen
      • 2.6.1 Business Overview
      • 2.6.2 Clinical Next-Generation Sequencing Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Qiagen Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Clinical Next-Generation Sequencing Market Competition, by Players

    • 3.1 Global Clinical Next-Generation Sequencing Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Clinical Next-Generation Sequencing Players Market Share
      • 3.2.2 Top 10 Clinical Next-Generation Sequencing Players Market Share
    • 3.3 Market Competition Trend

    4 Global Clinical Next-Generation Sequencing Market Size by Regions

    • 4.1 Global Clinical Next-Generation Sequencing Revenue and Market Share by Regions
    • 4.2 North America Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 4.5 South America Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

    5 North America Clinical Next-Generation Sequencing Revenue by Countries

    • 5.1 North America Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)
    • 5.2 USA Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

    6 Europe Clinical Next-Generation Sequencing Revenue by Countries

    • 6.1 Europe Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)
    • 6.2 Germany Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 6.3 UK Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 6.4 France Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Countries

    • 7.1 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)
    • 7.2 China Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 7.5 India Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

    8 South America Clinical Next-Generation Sequencing Revenue by Countries

    • 8.1 South America Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)
    • 8.2 Brazil Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Clinical Next-Generation Sequencing by Countries

    • 9.1 Middle East and Africa Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

    10 Global Clinical Next-Generation Sequencing Market Segment by Type

    • 10.1 Global Clinical Next-Generation Sequencing Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Clinical Next-Generation Sequencing Market Forecast by Type (2019-2024)
    • 10.3 Targeted Sequencing Revenue Growth Rate (2014-2024)
    • 10.4 Exome Sequencing Revenue Growth Rate (2014-2024)
    • 10.5 Others Revenue Growth Rate (2014-2024)

    11 Global Clinical Next-Generation Sequencing Market Segment by Application

    • 11.1 Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2014-2019)
    • 11.2 Clinical Next-Generation Sequencing Market Forecast by Application (2019-2024)
    • 11.3 Hospitals and Clinics Revenue Growth (2014-2019)
    • 11.4 Biopharma Companies Revenue Growth (2014-2019)
    • 11.5 Academic and Research Organizations Revenue Growth (2014-2019)
    • 11.6 Others Revenue Growth (2014-2019)

    12 Global Clinical Next-Generation Sequencing Market Size Forecast (2019-2024)

    • 12.1 Global Clinical Next-Generation Sequencing Market Size Forecast (2019-2024)
    • 12.2 Global Clinical Next-Generation Sequencing Market Forecast by Regions (2019-2024)
    • 12.3 North America Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)
    • 12.4 Europe Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)
    • 12.6 South America Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Clinical Next-Generation Sequencing . Industry analysis & Market Report on Clinical Next-Generation Sequencing is a syndicated market report, published as Global Clinical Next-Generation Sequencing Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Clinical Next-Generation Sequencing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,784.00
      4,176.00
      5,568.00
      3,250.32
      4,875.48
      6,500.64
      547,508.40
      821,262.60
      1,095,016.80
      290,197.20
      435,295.80
      580,394.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report